Apotex Health Q2 Adj. EPS $0.57 Beats $0.42 Estimate, Sales $852.900M Beat $828.594M Estimate

Apotex Health (TSX:APTX) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.42 by 35.71 percent. This is a 6.56 percent decrease over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $852.900 million which beat the analyst consensus estimate of $828.594 million by 2.93 percent. This is a 1.11 percent increase over sales of $843.500 million the same period last year.